Patents by Inventor Michael W. Decker

Michael W. Decker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150313891
    Abstract: An embodiment relates to a selective agonist of neuronal nicotinic acetylcholine receptor ?7 subtype, a pharmaceutically suitable salt, prodrug, or a metabolite thereof, for the prevention and treatment of diseases and conditions that are mediated by nicotinic acetylcholine receptors, and methods of use thereof. Another embodiment is a method of administering a pharmaceutically effective amount of a selective agonist of neuronal nicotinic acetylcholine receptor ?7 subtype, or a pharmaceutically suitable salt, prodrug, or a metabolite thereof, to a mammal in need thereof.
    Type: Application
    Filed: May 1, 2015
    Publication date: November 5, 2015
    Inventor: Michael W. Decker
  • Publication number: 20140296493
    Abstract: The invention describes methods of treating depression comprising administering a TNF? antibody, such as a human TNF? antibody.
    Type: Application
    Filed: February 5, 2014
    Publication date: October 2, 2014
    Applicant: ABBVIE BIOTECHNOLOGY LTD.
    Inventors: Rebecca S. Hoffman, Michael W. Decker, Ana M. Basso, Lynne E. Rueter, Walid M. Abi-saab
  • Publication number: 20110269708
    Abstract: The present invention provides methods to treat mood disorders and anxiety disorders using antagonists of the P2X7 receptor and pharmaceutical compositions thereof, or combinations.
    Type: Application
    Filed: July 11, 2011
    Publication date: November 3, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: Natalie A. Bratcher, Lynne E. Rueter, Michael W. Decker, Richard R. Harris, Michael F. Jarvis, William A. Carroll, Ana M. Basso
  • Publication number: 20100113380
    Abstract: The present invention provides methods to treat mood disorders and anxiety disorders using antagonists of the P2X7 receptor and pharmaceutical compositions thereof, or combinations.
    Type: Application
    Filed: October 19, 2009
    Publication date: May 6, 2010
    Inventors: Natalie A. Bratcher, Lynne E. Rueter, Michael W. Decker, Richard R. Harris, Michael F. Jarvis, William A. Carroll, Ana M. Basso
  • Patent number: 5272155
    Abstract: Pharmaceutical compositions comprising a therapeutically effective amount of (+) 2-methylpiperidine and a pharmaceutically-acceptable carrier or diluent, as well as to a method of treating cognitive, neurological and mental disorders, which are characterized by decreased cholinergic function in humans and lower mammals, by administration of (+)2-methylpiperidine, optionally with a nicotinic agonist.
    Type: Grant
    Filed: December 5, 1991
    Date of Patent: December 21, 1993
    Assignee: Abbott Laboratories
    Inventors: Stephen P. Arneric, Michael W. Decker
  • Patent number: 5174543
    Abstract: A tipover prevention apparatus for an appliance includes a wall-mounted bracket which secures an appliance tether cable extending horizontally across the wall-facing side of the appliance. The bracket includes a plurality of downwardly extending hooks for removably securing the appliance tether cable, each of which hooks includes an interior relieved area in which the appliance tether cable is positioned. A pair of forwardly extending ridges located on the extreme right and left edges of the bracket impart tension to the appliance tether cable, maintaining the appliance tether cable in proper position.
    Type: Grant
    Filed: December 23, 1991
    Date of Patent: December 29, 1992
    Assignee: Whirlpool Corporation
    Inventors: David N. Corson, Michael W. Decker